MyMenoplan Website Empowers Women in Menopause Management Decisions

A recent study published in the journal Maturitas has demonstrated that the MyMenoplan website significantly enhances women’s knowledge about menopause, improves treatment awareness, and boosts decision-making confidence. This online platform, developed by the research network Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH), aims to provide evidence-based information and treatment options specifically for women navigating the complexities of menopause.

The study, conducted between January 12 and January 26, 2022, recruited 410 participants aged 40 to 60 years who identified as either perimenopausal or experiencing menopause-related symptoms. Participants were divided into two groups: one that accessed the MyMenoplan website and another control group allowed to browse any site of their choice. After 20 minutes of browsing, participants completed a survey evaluating their knowledge and decision-making progress regarding menopause.

According to Dr. Andrea LaCroix, PhD, MPH, principal investigator of the study and a distinguished researcher at the University of California, San Diego, the MyMenoplan website includes over 72 pages of information about menopause, interactive tools, and personal narratives from women who have undergone similar experiences. "This tool guides a person through a discussion of their symptoms, explains why these symptoms are common during menopause, and outlines the treatment options available," LaCroix stated in a press release on July 24, 2025.

The results indicated that women who accessed the MyMenoplan platform were significantly more likely to report an intention to change their treatment, had increased knowledge of menopause, and felt better prepared to discuss their symptoms with healthcare providers. Specifically, 52% of participants reported experiencing perimenopausal symptoms with an extremely high burden, including physiological symptoms at 99.5%, psychological symptoms at 97%, vasomotor symptoms at 82%, and sexual symptoms at 64%.

Despite these positive outcomes, the study also revealed that there was no significant difference between the two groups regarding their intent to speak with their healthcare provider or their feelings of preparedness for such discussions. However, participants using MyMenoplan did report higher scores on decision-making progress and clarity of values.

Dr. LaCroix emphasized the importance of breaking the silence surrounding menopause, stating, "It’s time to bring menopause into the public conversation—because awareness is the first step toward better health outcomes." This sentiment is echoed in the broader context of women’s health, which has often been sidelined in medical discourse.

The findings from this study resonate with ongoing discussions in the medical community about the need for improved health literacy among women regarding menopause. According to Dr. Lisa Snyder, a gynecologist and member of the North American Menopause Society, it is crucial that women are equipped with accurate information that empowers them to make informed decisions regarding their health. "Access to resources like MyMenoplan can facilitate meaningful conversations between women and their healthcare providers, ultimately leading to better health outcomes," Snyder remarked in an interview.

Furthermore, the need for comprehensive resources on menopause is supported by the World Health Organization, which highlights that health systems should be responsive to the specific needs of women during this transition. By providing a platform that encourages women to engage actively with their healthcare, MyMenoplan represents a significant advancement in menopause education and management.

As the conversation around menopause continues to evolve, the role of technology in enhancing health literacy and empowering women cannot be understated. The MyMenoplan initiative not only reflects a growing recognition of the complexities of menopause but also serves as a model for future interventions aimed at improving women’s health outcomes. With increased awareness and access to tailored resources, women can take charge of their menopause journey, fostering a culture of openness and support.

In future studies, it will be important to assess the long-term impact of platforms like MyMenoplan on treatment adherence and satisfaction among women experiencing menopause. As discussions about women's health evolve, the necessity for informed, evidence-based approaches to menopause management will undoubtedly remain a priority for both healthcare providers and patients alike.